MX2009007790A - Mejora del crecimiento celular. - Google Patents

Mejora del crecimiento celular.

Info

Publication number
MX2009007790A
MX2009007790A MX2009007790A MX2009007790A MX2009007790A MX 2009007790 A MX2009007790 A MX 2009007790A MX 2009007790 A MX2009007790 A MX 2009007790A MX 2009007790 A MX2009007790 A MX 2009007790A MX 2009007790 A MX2009007790 A MX 2009007790A
Authority
MX
Mexico
Prior art keywords
cell growth
improvement
concerns
growth
biopharmaceutical
Prior art date
Application number
MX2009007790A
Other languages
English (en)
Inventor
Hitto Kaufmann
Lore Florin
Eric Becker
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MX2009007790A publication Critical patent/MX2009007790A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Abstract

La invención se refiere al campo de la tecnología de cultivo celular. Se refiere a un procedimiento de mejorar el crecimiento celular, especialmente el crecimiento de células huéspedes de los fabricantes de compuestos biofarmacéuticos. La invención se refiere, además, a un procedimiento para producir proteínas utilizando las células generadas por el procedimiento descrito.
MX2009007790A 2007-01-24 2008-01-22 Mejora del crecimiento celular. MX2009007790A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07101070A EP1953222A1 (en) 2007-01-24 2007-01-24 Improvement of cell growth
PCT/EP2008/050699 WO2008090148A2 (en) 2007-01-24 2008-01-22 Improvement of cell growth

Publications (1)

Publication Number Publication Date
MX2009007790A true MX2009007790A (es) 2009-07-31

Family

ID=38006916

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007790A MX2009007790A (es) 2007-01-24 2008-01-22 Mejora del crecimiento celular.

Country Status (14)

Country Link
US (1) US8535940B2 (es)
EP (2) EP1953222A1 (es)
JP (1) JP2010516264A (es)
KR (1) KR20090112725A (es)
CN (1) CN101589140B (es)
AU (1) AU2008208862B2 (es)
BR (1) BRPI0807798A2 (es)
CA (1) CA2675344A1 (es)
EA (1) EA018099B1 (es)
HK (1) HK1137482A1 (es)
IL (1) IL199639A (es)
MX (1) MX2009007790A (es)
NZ (1) NZ579204A (es)
WO (1) WO2008090148A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1953222A1 (en) 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
US8962312B2 (en) 2008-07-23 2015-02-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Production host cell lines
SG173457A1 (en) 2009-02-27 2011-09-29 Novartis Ag Methods for selecting eukaryotic cells expressing a heterologous protein
CN108646019B (zh) 2012-12-10 2021-06-25 生化学工业株式会社 新重组因子c、其制造方法、及内毒素的测定法
SG11201703741TA (en) * 2014-11-12 2017-06-29 Prometic Pharma Smt Ltd Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
CN107119018B (zh) * 2017-03-30 2020-08-18 陕西师范大学 一种抗凋亡细胞系及其建立方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
ATE289350T1 (de) 1989-04-21 2005-03-15 Amgen Inc Tnf-rezeptor, tnf bindende proteine und dafür kodierende dnas
US5776746A (en) 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
EP1348758A1 (en) * 2002-03-28 2003-10-01 Boehringer Ingelheim Pharma GmbH & Co.KG Host cells having improved cell survival properties and methods to generate such cells
US20030219871A1 (en) 2002-03-28 2003-11-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Host cells having improved cell survival properties and methods to generate such cells
EP1953222A1 (en) 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth

Also Published As

Publication number Publication date
HK1137482A1 (en) 2010-07-30
EA018099B1 (ru) 2013-05-30
JP2010516264A (ja) 2010-05-20
IL199639A (en) 2013-08-29
WO2008090148A3 (en) 2008-09-18
IL199639A0 (en) 2010-04-15
US8535940B2 (en) 2013-09-17
NZ579204A (en) 2012-04-27
KR20090112725A (ko) 2009-10-28
CN101589140B (zh) 2013-04-17
EP2126061A2 (en) 2009-12-02
AU2008208862B2 (en) 2014-05-08
CA2675344A1 (en) 2008-07-31
CN101589140A (zh) 2009-11-25
EA200900984A1 (ru) 2010-02-26
BRPI0807798A2 (pt) 2014-06-03
US20100086967A1 (en) 2010-04-08
AU2008208862A1 (en) 2008-07-31
WO2008090148A2 (en) 2008-07-31
EP1953222A1 (en) 2008-08-06

Similar Documents

Publication Publication Date Title
UA92157C2 (ru) Способ продуцирования гормона роста
MY185887A (en) Cell culture improvements
UA103363C2 (ru) Способ ферментативного производства четырехатомных спиртов
WO2010096588A3 (en) Cell culture media containing combinations of proteins
SG10201810830UA (en) Cell culture compositions and methods for polypeptide production
EA201300074A1 (ru) Способ получения представляющего интерес соединения
MX2010002990A (es) Produccion de isoprenoides.
MY146612A (en) Production of isoprenoids
WO2008118820A3 (en) Somatic cell reprogramming
NZ602201A (en) A novel ethanologenic clostridium species, clostridium coskatii
SG10201408300PA (en) Processing of amplified dna fragments for sequencing
MY147186A (en) Biofuel production by recombinant microorganisms
MX2011006301A (es) Produccion de alcoholes de cadena ramificada por medio de microorganismos fotosinteticos.
MX2009008175A (es) Metodos para producir vacunas basadas en levadura.
EA200900286A1 (ru) Модификация бактерий для получения этанола
EP2516624A4 (en) CELL LINE 3M
MX2009007790A (es) Mejora del crecimiento celular.
WO2018203947A3 (en) MODIFIED BIOSYNTHESIS PATHWAYS FOR FERMENTATION TYRAMINE PRODUCTION
GB2468624A (en) Cell culture system for pancreatic islands
WO2007130543A3 (en) Method for producing stable mammalian cell lines producing high levels of recombinant proteins
MY159439A (en) Method for producing glucosidase, enzyme composition, and method for hydrolyzing biomass
EP2211625A4 (en) MUSHROOMS AND A METHOD FOR MAKING AN INSECTICIDE OF THESE STEELS
RU2011115880A (ru) Способ получения селенсодержащего препарата биомассы laetiporus sulphureus mz-22
DK1893743T3 (da) Fremgangsmåde til dyrkning af bakterier af familien streptococcaceae
UA44814U (ru) СПОСОБ СУПЕРСИНТЕЗА РЕКОМБИНАНТНОГО БЕЛКА rExhCD34 ПРОДУЦЕНТОМ ШТАММА Е.COLI BL21hCD34

Legal Events

Date Code Title Description
FG Grant or registration